Dr. Renuka Iyer has been appointed as the new Chief Medical Officer (CMO) of the National Comprehensive Cancer Network (NCCN), marking a significant addition to the organisation’s clinical leadership. She brings extensive expertise in oncology, cancer research, and evidence-based guideline development.
With a distinguished career in hematology-oncology, Dr. Iyer has been widely recognised for her contributions to patient care, clinical innovation, and advancing cancer treatment protocols. Her experience spans academic medicine, clinical research, multidisciplinary programme development, and leadership roles in cancer care systems.
In her new position at NCCN, Dr. Iyer will oversee the organisation’s medical strategy, guide the evolution of its global clinical practice guidelines, and support efforts to expand equitable, high-quality cancer care worldwide. Her leadership will also contribute to strengthening NCCN’s collaborations with clinicians, researchers, and health institutions across the oncology ecosystem.
Dr. Renuka Iyer has formally assumed her responsibilities as CMO and is expected to play a pivotal role in shaping NCCN’s strategic direction in the years ahead.
